# Drug Occurrence OMOP Table - Data Management with FHIR v0.1.0

 ![](assets/images/aphp-logo.png) 

*  [Accueil](index.md) 
*  [Dictionnaire des données](data-dictionary.md) 
*  [Variables du socle commun **** ](#) 
*  [Acquisition des variables](use-core-variables-acquisition.md) 
*  [Formalisation des variables](use-core-variables-formalization.md) 
*  [Standardisation des variables](use-core-variables-standardization.md) 
 
*  [Health Data Platform **** ](#) 
*  [Architecture fonctionnelle](data-platform-functional-architecture.md) 
*  [Raw layer](data-platform-raw-layer.md) 
*  [Transform layer](data-platform-transform-layer.md) 
*  [Semantic layer](data-platform-semantic-layer.md) 
*  [Share layer](data-platform-share-layer.md) 
 
*  [Guide **** ](#) 
*  [Gestion des données](https://interop.aphp.fr/ig/fhir/core/data-management.html) 
*  [Bonnes pratiques](https://interop.aphp.fr/ig/fhir/core/best-practice.html) 
*  [Processus de standardisation des données](https://interop.aphp.fr/ig/fhir/core/standardization-process.html) 
 
*  [Ressources de conformité](artifacts.md) 
*  [Autres **** ](#) 
*  [Aide](help.md) 
*  [Notes de version](changelog.md) 
*  [Glossaire](glossary.md) 
*  [Télécharger spécifications](downloads.md) 
 

* [Accueil](index.md)
* [Dictionnaire des données](data-dictionary.md)
* [Usages](use-case.md)
* [Variables socles pour les EDSH](use-core-variables.md)
* [Standardisation de données au format FHIR](use-core-variables-process.md)
* [Acquisition des variables](use-core-variables-acquisition.md)
* [Formalisation des variables](use-core-variables-formalization.md)
* [Standardisation des variables](use-core-variables-standardization.md)
* [Evaluation](use-core-variables-evaluation.md)
* [Health Data Platform (démo)](data-platform.md)
* [Architecture fonctionnelle](data-platform-functional-architecture.md)
* [Raw layer](data-platform-raw-layer.md)
* [Transform layer](data-platform-transform-layer.md)
* [Semantic layer](data-platform-semantic-layer.md)
* [Share layer](data-platform-share-layer.md)
* [Autre](other.md)
* [Aide](help.md)
* [Notes de version](changelog.md)
* [Glossaire](glossary.md)
* [Télécharger les spécifications](downloads.md)
* [Artifacts Summary](artifacts.md)
* [CareSite OMOP Table](StructureDefinition-OMOPCareSite.md)
* [Concept OMOP Table](StructureDefinition-OMOPConcept.md)
* [Condition Era OMOP Table](StructureDefinition-OMOPConditionEra.md)
* [Condition Occurrence OMOP Table](StructureDefinition-OMOPConditionOccurrence.md)
* [Cost OMOP Table](StructureDefinition-OMOPCost.md)
* [Death OMOP Table](StructureDefinition-OMOPDeath.md)
* [Device Exposure OMOP Table](StructureDefinition-OMOPDeviceExposure.md)
* [Dose Era OMOP Table](StructureDefinition-OMOPDoseEra.md)
* [Drug Era OMOP Table](StructureDefinition-OMOPDrugEra.md)
* [Drug Occurrence OMOP Table](StructureDefinition-OMOPDrugExposure.md)
* [Electronic Health Record Data Model](StructureDefinition-ehr.md)
* [Episode Event OMOP Table](StructureDefinition-OMOPEpisodeEvent.md)
* [Episode OMOP Table](StructureDefinition-OMOPEpisode.md)
* [Fact Relationship OMOP Table](StructureDefinition-OMOPFactRelationship.md)
* [Location OMOP Table](StructureDefinition-OMOPLocation.md)
* [LogicalBundle](StructureDefinition-LogicalBundle.md)
* [Measurement OMOP Table](StructureDefinition-OMOPMeasurement.md)
* [Note NLP OMOP Table](StructureDefinition-OMOPNoteNLP.md)
* [Note OMOP Table](StructureDefinition-OMOPNote.md)
* [Observation OMOP Table](StructureDefinition-OMOPObservation.md)
* [Observation Period OMOP Table](StructureDefinition-OMOPObservationPeriod.md)
* [Payer Plan Period OMOP Table](StructureDefinition-OMOPPayerPlanPeriod.md)
* [Person OMOP Table](StructureDefinition-OMOPPerson.md)
* [Procedure Occurrence OMOP Table](StructureDefinition-OMOPProcedureOccurrence.md)
* [Provider OMOP Table](StructureDefinition-OMOPProvider.md)
* [Specimen OMOP Table](StructureDefinition-OMOPSpecimen.md)
* [Visit Detail OMOP Table](StructureDefinition-OMOPVisitDetail.md)
* [Visit Occurrence OMOP Table](StructureDefinition-OMOPVisitOccurrence.md)
* [Questionnaire usage Variables socles pour les EDSH](Questionnaire-UsageCore.md)
* [Profil de Claim pour le champ MCO du PMSI](StructureDefinition-DMClaimPMSIMCO.md)
* [Profil de Claim pour le PMSI](StructureDefinition-DMClaimPMSI.md)
* [Résultat de laboratoire](StructureDefinition-DMObservationLaboratoryGeneric.md)
* [Activité physique](StructureDefinition-DMObservationExerciceStatus.md)
* [Alanine aminotransférase (ALAT)](StructureDefinition-DMObservationLaboratoryALAT.md)
* [Aspartate aminotransférase (ASAT)](StructureDefinition-DMObservationLaboratoryASAT.md)
* [Bilirubine conjuguée](StructureDefinition-DMObservationLaboratoryBilirubineConjuguee.md)
* [Bilirubine totale](StructureDefinition-DMObservationLaboratoryBilirubineTotale.md)
* [Condition](StructureDefinition-DMCondition.md)
* [Consommation d'alcool](StructureDefinition-DMObservationAlcoholUseStatus.md)
* [Consommation d'autres drogues](StructureDefinition-DMObservationSubstanceUseStatus.md)
* [Consommation de tabac](StructureDefinition-DMObservationSmokingStatus.md)
* [Encounter](StructureDefinition-DMEncounter.md)
* [Eosinophiles](StructureDefinition-DMObservationLaboratoryEosinophiles.md)
* [Episode of care](StructureDefinition-DMEpisodeOfCare.md)
* [Erythrocytes](StructureDefinition-DMObservationLaboratoryErythrocytes.md)
* [Fonction rénale](StructureDefinition-DMObservationLaboratoryFonctionRenale.md)
* [French branded name Medication](StructureDefinition-FrMedicationUcd.md)
* [French compound Medication](StructureDefinition-FrMedicationCompound.md)
* [French non proprietary name Medication](StructureDefinition-FrMedicationNonproprietaryName.md)
* [French Ucd Part Medication](StructureDefinition-FrMedicationUcdPart.md)
* [Gamma-glutamyl transférase (GGT)](StructureDefinition-DMObservationLaboratoryGGT.md)
* [Glycémie à jeun](StructureDefinition-DMObservationLaboratoryGlycemieAJeun.md)
* [Hématocrite](StructureDefinition-DMObservationLaboratoryHematocrite.md)
* [Hémoglobine](StructureDefinition-DMObservationLaboratoryHemoglobine.md)
* [Hémoglobine glyquée](StructureDefinition-DMObservationLaboratoryHbA1c.md)
* [Leucocytes](StructureDefinition-DMObservationLaboratoryLeucocytes.md)
* [Location](StructureDefinition-DMLocation.md)
* [Lymphocytes](StructureDefinition-DMObservationLaboratoryLymphocytes.md)
* [Monocytes](StructureDefinition-DMObservationLaboratoryMonocytes.md)
* [Neutrophiles](StructureDefinition-DMObservationLaboratoryNeutrophiles.md)
* [Organization](StructureDefinition-DMOrganization.md)
* [Patient](StructureDefinition-DMPatient.md)
* [Phosphatases alcaline](StructureDefinition-DMObservationLaboratoryPAL.md)
* [Plaquettes](StructureDefinition-DMObservationLaboratoryPlaquettes.md)
* [Poids du patient](StructureDefinition-DMObservationBodyWeight.md)
* [Practitioner](StructureDefinition-DMPractitioner.md)
* [PractitionerRole](StructureDefinition-DMPractitionerRole.md)
* [Prescription de médicaments](StructureDefinition-DMMedicationRequest.md)
* [Pression artérielle](StructureDefinition-DMObservationBloodPressure.md)
* [Prise de médicaments](StructureDefinition-DMMedicationAdministration.md)
* [Procedure](StructureDefinition-DMProcedure.md)
* [RUM du PMSI MCO](StructureDefinition-DMClaimRUM.md)
* [Taille du patient](StructureDefinition-DMObservationBodyHeight.md)
* [Taux prothrombine (TP)](StructureDefinition-DMObservationLaboratoryTP.md)
* [Temps de céphaline activée (TCA)](StructureDefinition-DMObservationLaboratoryTCA.md)
* [Urée](StructureDefinition-DMObservationLaboratoryUremie.md)
* [Volume globulaire moyen](StructureDefinition-DMObservationLaboratoryVGM.md)
* [Address](StructureDefinition-DMAddress.md)
* [Range with UCUM quantity units](StructureDefinition-FrRangeUcum.md)
* [Ratio with UCUM quantity units](StructureDefinition-FrRatioUcum.md)
* [SimpleQuantity with UCUM quantity unit](StructureDefinition-FrSimpleQuantityUcum.md)
* [Codage géographique du lieu de résidence pour les RSA du PMSI](StructureDefinition-PmsiCodeGeo.md)
* [Groupe Homogène de Malade](StructureDefinition-DRG.md)
* [Ordre des Item dans un claim](StructureDefinition-ItemRank.md)
* [Source ayant fournie l'information de décès](StructureDefinition-DeathSource.md)
* [Actes CCAM pour le PMSI](ValueSet-CcamVS.md)
* [Blood Pressure Measurement Body Location Precoordinated](ValueSet-BloodPressureMeasurementBodyLocationPrecoodinated.md)
* [Blood Pressure Measurement Method](ValueSet-BloodPressureMeasurementMethod.md)
* [Categorisation des items de claim pour le PMSI MCO](ValueSet-FrMCOClaimItemCategory.md)
* [Exercice Status Type](ValueSet-DMExerciceStatusType.md)
* [French Medicinal product Dose form](ValueSet-FrMpDoseForm.md)
* [French Medicinal Product only](ValueSet-FrMedicinalProductOnly.md)
* [French Route of Administration](ValueSet-FrRouteOfAdministration.md)
* [Height Length Measurement Method](ValueSet-HeightLengthMeasurementMethod.md)
* [Liste des analyses biologiques socle des EDS](ValueSet-DMLaboratory.md)
* [Liste des analyses correspondant à l'estimation du DFG - socle des EDS](ValueSet-DMLaboratoryEstimatedDFG.md)
* [Liste des diagnostiques CIM-10 acceptable en DA pour les PMSI MCO et HAD](ValueSet-CIM10PMSIDA.md)
* [Liste des diagnostiques CIM-10 acceptable en DP pour les PMSI MCO et HAD](ValueSet-CIM10PMSIDP.md)
* [Liste des diagnostiques CIM-10 acceptable en DR pour les PMSI MCO et HAD](ValueSet-CIM10PMSIDR.md)
* [Liste des diagnostiques CIM-10 OMS](ValueSet-CIM10.md)
* [Liste des diagnostiques CIM-10 pour le PMSI](ValueSet-CIM10PMSI.md)
* [Liste des GHM pour le PMSI MCO](ValueSet-GHMVS.md)
* [Liste des status pour l'Observation de consommation de tabac](ValueSet-DMObservationSmokingStatusStatus.md)
* [Liste des unités possibles pour une estimation du débit de filtration glomérulaire - socle des EDS](ValueSet-DMLaboratoryEstimatedDFGUnit.md)
* [Mode d'entré du PMSI MCO](ValueSet-PMSIMCOMDEVS.md)
* [Mode de sortie du PMSI MCO](ValueSet-PMSIMCOMDSVS.md)
* [Smoking status comprehensive](ValueSet-DMSmokingStatusComprehensive.md)
* [Smoking Status Pack Years SCT](ValueSet-DMSmokingStatusPackYearsSCT.md)
* [Smoking Status Type](ValueSet-DMSmokingStatusType.md)
* [Smoking Status Type from LOINC](ValueSet-DMSmokingStatusTypeLOINC.md)
* [ValueSet des codes géographiques de résidence du PMSI](ValueSet-PmsiCodeGeoVs.md)
* [ValueSet des modes d'entrée du DPI](ValueSet-DpiModeIn.md)
* [ValueSet des modes de sortie du DPI](ValueSet-DpiModeOut.md)
* [ValueSet des Sexe administratif du DPI](ValueSet-DpiGenderVS.md)
* [ValueSet des sources d'informations fr sur le statut vital](ValueSet-DeathSourcesVs.md)
* [ValueSet des type fr des claims](ValueSet-FrClaimType.md)
* [ValueSet des type fr des claims](ValueSet-FrMCOClaimSubType.md)
* [ValueSet des types de séjour du DPI](ValueSet-DpiEncounterTypeVS.md)
* [ValueSet of gender of OHDSI](ValueSet-OMOPGender.md)
* [Weight Measurement Method](ValueSet-WeightMeasurementMethod.md)
* [Cadre de facturation dans la réglementation française](CodeSystem-FrClaimType.md)
* [Categorie d'information pour les supporting information](CodeSystem-FrClaimSupInfoCategoryPMSIMCO.md)
* [Categorisation des items de claim pour le PMSI MCO](CodeSystem-FrMCOClaimItemCategory.md)
* [CCAM illustrative](CodeSystem-Ccam.md)
* [CIM 10 PMSI](CodeSystem-CIM10.md)
* [Classification des GHM utilisée pour le groupage des séjours dans le PMSI MCO.](CodeSystem-GHM.md)
* [CodeSystem des lieux de résidence géographique au sens du PMSI](CodeSystem-PmsiCodeGeo.md)
* [DPI Gender](CodeSystem-DpiGender.md)
* [Dpi Mode d'entrée](CodeSystem-DpiModeIn.md)
* [Dpi Mode de sortie](CodeSystem-DpiModeOut.md)
* [DPI Type de séjour](CodeSystem-DpiEncounterType.md)
* [Mode d'entré du PMSI MCO](CodeSystem-PMSIMCOMDE.md)
* [Mode de sortie du PMSI MCO](CodeSystem-PMSIMCOMDS.md)
* [mode PMSI](CodeSystem-FrClaimMode.md)
* [Observational Medical Outcomes Partnership (OMOP)](CodeSystem-dm-omop-cdm-v20240229.md)
* [SNOMED CT Solor Extension Temporary](CodeSystem-SolorTemporary.md)
* [Sources susceptibles d'informer sur le statu vital des patients](CodeSystem-DeathSources.md)
* [Specialités médicales au sens de la Fédération des Spécialités Médicales (FSM)](CodeSystem-SpecialitesMedicalesFSM.md)
* [type de diagnostic du PMSI MCO](CodeSystem-PMSIMCODiagType.md)
* [Transforms EHR logical model data to FHIR Semantic Layer resources using Bundle as container](StructureMap-EHR2FSL.md)
* [Transforms QuestionnaireResponse based on Questionnaire Usage Variables socles into FHIR resources conforming to DM profiles](StructureMap-Q2FSL.md)
* [Alignement de l''expression de besoin vers le modèle physique du DPI dans le cadre de l''usage Core](StructureMap-CoreBusiness2Physical.md)
* [Cette ressource présente les spécifications de l''alignement entre les ressources FHIR vers les tables correspodantes du CDM OMOP.](StructureMap-CoreFHIR2OMOP.md)
* [Mapping FHIR Patient resource to OMOP Death](StructureMap-CoreFHIR2OMOPDeath.md)
* [Mapping Patient resource to Location OMOP Domain](StructureMap-CoreFHIR2OMOPLocation.md)
* [Mapping Observation laboratory resources to Measurement OMOP Domain](StructureMap-CoreFHIR2OMOPMeasurement.md)
* [Mapping FHIR Patient resource to OMOP Person](StructureMap-CoreFHIR2OMOPPerson.md)
* [Cette ressource présente les spécifications de l''alignement entre la ressource `Patient` vers les tables correspodantes du CDM OMOP.](StructureMap-CoreFHIRPatient2OMOP.md)
* [Alignement de l''usage Core du modèle physique du DPI vers les ressources FHIR](StructureMap-CorePhysical2FHIR.md)
* [Mapping simple Observation laboratory resources to Measurement OMOP Domain](StructureMap-CoreSimpleObservation2OMOPMeasurement.md)
* [DPI (local) Gender to HL7 Gender](ConceptMap-dpi-gender-2-hl7-gender.md)
* [DPI Encounter type to Semantic layer](ConceptMap-dpi-encounter-type-2-semantic-layer-encounter-class.md)
* [HL7 Gender to OHDSI Gender](ConceptMap-hl7-gender-to-ohdsi-gender.md)
* [Administration d'albumine de Madame Blanc](MedicationAdministration-albumine-j1-cas-9.md)
* [Administration à J1 de furosemide de Madame Blanc](MedicationAdministration-furosemide-j1-cas-9.md)
* [Administration à J1 de spironolactone de Madame Blanc](MedicationAdministration-spironolactone-j1-cas-9.md)
* [Administration à J2 de furosemide de Madame Blanc](MedicationAdministration-furosemide-j2-cas-9.md)
* [Administration à J2 de spironolactone de Madame Blanc](MedicationAdministration-spironolactone-j2-cas-9.md)
* [ALAT de Madame Blanc](Observation-alat-cas-9.md)
* [Albumine](Medication-albumine.md)
* [ASAT de Madame Blanc](Observation-asat-cas-9.md)
* [Ascite de Madame Blanc](Condition-ascite-cas-9.md)
* [Bilirubine totale de Madame Blanc](Observation-bilirubine-totale-cas-9.md)
* [Cirrhose de Madame Blanc](Condition-cirrhose-cas-9.md)
* [Consommation d'alcool de Madame Blanc](Observation-alcool-cas-9.md)
* [de Madame Blanc](Patient-cas-9.md)
* [Exemple complet (FSL)](Bundle-df9c9a9c-854b-46f4-9687-1fbe40c06540.md)
* [Exemple simple](QuestionnaireResponse-test-usage-core.md)
* [Fibroscopie oeso-gastroduodénale de Madame Blanc](Procedure-fogd-cas-9.md)
* [Furosémide](Medication-furosemide.md)
* [GGT de Madame Blanc](Observation-ggt-cas-9.md)
* [Patient 1 - Madame Dupont](QuestionnaireResponse-cas-1-usage-core.md)
* [Patient 10 - Monsieur David](QuestionnaireResponse-cas-10-usage-core.md)
* [Patient 11 - Madame Doré](QuestionnaireResponse-cas-11-usage-core.md)
* [Patient 2 - Monsieur Martin](QuestionnaireResponse-cas-2-usage-core.md)
* [Patient 3 - Madame Leroy](QuestionnaireResponse-cas-3-usage-core.md)
* [Patient 4 - Monsieur Moreau](QuestionnaireResponse-cas-4-usage-core.md)
* [Patient 5 - Madame Simon](QuestionnaireResponse-cas-5-usage-core.md)
* [Patient 6 - Monsieur Petit](QuestionnaireResponse-cas-6-usage-core.md)
* [Patient 7 - Madame Garcia](QuestionnaireResponse-cas-7-usage-core.md)
* [Patient 8 - Monsieur Roux](QuestionnaireResponse-cas-8-usage-core.md)
* [Patient 9 - Madame Blanc](QuestionnaireResponse-cas-9-usage-core.md)
* [Patient test (Bundle)](Bundle-5616f9ad-61b0-4279-9f41-777228d04665.md)
* [Patient test (Ressource)](Patient-8f005d60-b59b-47f7-b04a-f877378f8d68.md)
* [Phosphatases alcalines de Madame Blanc](Observation-phosphatases-alcalines-cas-9.md)
* [Poids de Madame Blanc](Observation-poids-cas-9.md)
* [Ponction évacuatrice de Madame Blanc](Procedure-ponction-cas-9.md)
* [Prescription d'albumine de Madame Blanc](MedicationRequest-albumine-cas-9.md)
* [Prescription de furosémide de Madame Blanc](MedicationRequest-furosemide-cas-9.md)
* [Prescription de furosémide de Madame Blanc](MedicationRequest-spironolactone-cas-9.md)
* [Spironolactone](Medication-spironolactone.md)
* [Séjour de Madame Blanc](Encounter-sejour-cas-9.md)
* [Taux de prothrombine de Madame Blanc](Observation-tp-cas-9.md)
* [Test simple](Bundle-2abf7f4c-bd1f-431f-a4c8-667cfa425baf.md)
* [Exigences des variables socles pour les Entrepôts de Données de Santé Hospitalier (EDSH)](DocumentReference-CoreExigences.md)

Data Management with FHIR
0.1.0 - ci-build

## Logical Model: Drug Occurrence OMOP Table 

| | |
| :--- | :--- |
| *Official URL*:https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPDrugExposure | *Version*:0.1.0 |
| Draft as of 2026-04-16 | *Computable Name*:OMOPDrugExposure |

 
This table captures records about the exposure to a Drug ingested or otherwise introduced into the body. A Drug is a biochemical substance formulated in such a way that when administered to a Person it will exert a certain biochemical effect on the metabolism. Drugs include prescription and over-the-counter medicines, vaccines, and large-molecule biologic therapies. Radiological devices ingested or applied locally do not count as Drugs. 

**Utilisations:**

* Ce Modèle logique n'est utilisé par aucun autre profil dans ce guide d'implémentation

Vous pouvez également vérifier [les usages dans le FHIR IG Statistics](https://packages2.fhir.org/xig/aphp.fhir.fr.dm|current/StructureDefinition/OMOPDrugExposure)

### Formal Views of Profile Content

 [Description of Profiles, Differentials, Snapshots and how the different presentations work](http://build.fhir.org/ig/FHIR/ig-guidance/readingIgs.html#structure-definitions). 

 

Other representations of profile: [CSV](StructureDefinition-OMOPDrugExposure.csv), [Excel](StructureDefinition-OMOPDrugExposure.xlsx) 



## Resource Content

```json
{
  "resourceType" : "StructureDefinition",
  "id" : "OMOPDrugExposure",
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-type-characteristics",
    "valueCode" : "can-be-target"
  }],
  "url" : "https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPDrugExposure",
  "version" : "0.1.0",
  "name" : "OMOPDrugExposure",
  "title" : "Drug Occurrence OMOP Table",
  "status" : "draft",
  "date" : "2026-04-16T14:35:38+00:00",
  "publisher" : "AP-HP",
  "contact" : [{
    "name" : "AP-HP",
    "telecom" : [{
      "system" : "url",
      "value" : "https://aphp.fr"
    }]
  }],
  "description" : "This table captures records about the exposure to a Drug ingested or otherwise introduced into the body. A Drug is a biochemical substance formulated in such a way that when administered to a Person it will exert a certain biochemical effect on the metabolism. Drugs include prescription and over-the-counter medicines, vaccines, and large-molecule biologic therapies. Radiological devices ingested or applied locally do not count as Drugs.",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "FR"
    }]
  }],
  "fhirVersion" : "4.0.1",
  "kind" : "logical",
  "abstract" : false,
  "type" : "https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPDrugExposure",
  "baseDefinition" : "http://hl7.org/fhir/StructureDefinition/Base",
  "derivation" : "specialization",
  "differential" : {
    "element" : [{
      "id" : "OMOPDrugExposure",
      "path" : "OMOPDrugExposure",
      "short" : "Drug Occurrence OMOP Table",
      "definition" : "This table captures records about the exposure to a Drug ingested or otherwise introduced into the body. A Drug is a biochemical substance formulated in such a way that when administered to a Person it will exert a certain biochemical effect on the metabolism. Drugs include prescription and over-the-counter medicines, vaccines, and large-molecule biologic therapies. Radiological devices ingested or applied locally do not count as Drugs."
    },
    {
      "id" : "OMOPDrugExposure.drug-exposure-id",
      "path" : "OMOPDrugExposure.drug_exposure_id",
      "short" : "Drug Exposure Identifier",
      "definition" : "The unique key given to records of drug dispensings or administrations for a person. Refer to the ETL for how duplicate drugs during the same visit were handled.",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "integer"
      }]
    },
    {
      "id" : "OMOPDrugExposure.person-id",
      "path" : "OMOPDrugExposure.person_id",
      "short" : "Person",
      "definition" : "The PERSON_ID of the PERSON for whom the drug dispensing or administration is recorded. This may be a system generated code.",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPPerson"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-concept-id",
      "path" : "OMOPDrugExposure.drug_concept_id",
      "short" : "Drug",
      "definition" : "The DRUG_CONCEPT_ID field is recommended for primary use in analyses, and must be used for network studies. This is the standard concept mapped from the source concept id which represents a drug product or molecule otherwise introduced to the body. The drug concepts can have a varying degree of information about drug strength and dose. This information is relevant in the context of quantity and administration information in the subsequent fields plus strength information from the DRUG_STRENGTH table, provided as part of the standard vocabulary download.",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPConcept"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-exposure-start-date",
      "path" : "OMOPDrugExposure.drug_exposure_start_date",
      "short" : "Drug Exposure Start Date",
      "definition" : "Use this date to determine the start date of the drug record.",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "date"
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-exposure-start-datetime",
      "path" : "OMOPDrugExposure.drug_exposure_start_datetime",
      "short" : "Drug Exposure Start Datetime",
      "definition" : "Drug Exposure Start Datetime",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "dateTime"
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-exposure-end-date",
      "path" : "OMOPDrugExposure.drug_exposure_end_date",
      "short" : "Drug Exposure End Date",
      "definition" : "The DRUG_EXPOSURE_END_DATE denotes the day the drug exposure ended for the patient.",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "date"
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-exposure-end-datetime",
      "path" : "OMOPDrugExposure.drug_exposure_end_datetime",
      "short" : "Drug Exposure End Datetime",
      "definition" : "Drug Exposure End Datetime",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "dateTime"
      }]
    },
    {
      "id" : "OMOPDrugExposure.verbatim-end-date",
      "path" : "OMOPDrugExposure.verbatim_end_date",
      "short" : "Verbatim End Date",
      "definition" : "This is the end date of the drug exposure as it appears in the source data, if it is given",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "date"
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-type-concept-id",
      "path" : "OMOPDrugExposure.drug_type_concept_id",
      "short" : "Drug Type",
      "definition" : "You can use the TYPE_CONCEPT_ID to delineate between prescriptions written vs. prescriptions dispensed vs. medication history vs. patient-reported exposure, etc.",
      "min" : 1,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPConcept"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.stop-reason",
      "path" : "OMOPDrugExposure.stop_reason",
      "short" : "Stop Reason",
      "definition" : "The reason a person stopped a medication as it is represented in the source. Reasons include regimen completed, changed, removed, etc. This field will be retired in v6.0.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "OMOPDrugExposure.refills",
      "path" : "OMOPDrugExposure.refills",
      "short" : "Refills",
      "definition" : "This is only filled in when the record is coming from a prescription written this field is meant to represent intended refills at time of the prescription.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "integer"
      }]
    },
    {
      "id" : "OMOPDrugExposure.quantity",
      "path" : "OMOPDrugExposure.quantity",
      "short" : "Quantity",
      "definition" : "Quantity",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "decimal"
      }]
    },
    {
      "id" : "OMOPDrugExposure.days-supply",
      "path" : "OMOPDrugExposure.days_supply",
      "short" : "Days Supply",
      "definition" : "Days Supply",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "integer"
      }]
    },
    {
      "id" : "OMOPDrugExposure.sig",
      "path" : "OMOPDrugExposure.sig",
      "short" : "Sig",
      "definition" : "This is the verbatim instruction for the drug as written by the provider.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "OMOPDrugExposure.route-concept-id",
      "path" : "OMOPDrugExposure.route_concept_id",
      "short" : "Route",
      "definition" : "Route",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPConcept"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.lot-number",
      "path" : "OMOPDrugExposure.lot_number",
      "short" : "Lot Number",
      "definition" : "Lot Number",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "OMOPDrugExposure.provider-id",
      "path" : "OMOPDrugExposure.provider_id",
      "short" : "Provider",
      "definition" : "The Provider associated with drug record, e.g. the provider who wrote the prescription or the provider who administered the drug.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPProvider"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.visit-occurrence-id",
      "path" : "OMOPDrugExposure.visit_occurrence_id",
      "short" : "Visit Occurrence",
      "definition" : "The Visit during which the drug was prescribed, administered or dispensed.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPVisitOccurrence"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.visit-detail-id",
      "path" : "OMOPDrugExposure.visit_detail_id",
      "short" : "Visit Detail",
      "definition" : "The VISIT_DETAIL record during which the drug exposure occurred. For example, if the person was in the ICU at the time of the drug administration the VISIT_OCCURRENCE record would reflect the overall hospital stay and the VISIT_DETAIL record would reflect the ICU stay during the hospital visit.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPVisitDetail"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-source-value",
      "path" : "OMOPDrugExposure.drug_source_value",
      "short" : "Drug Source Value",
      "definition" : "This field houses the verbatim value from the source data representing the drug exposure that occurred. For example, this could be an NDC or Gemscript code.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "OMOPDrugExposure.drug-source-concept-id",
      "path" : "OMOPDrugExposure.drug_source_concept_id",
      "short" : "Drug Source Concept",
      "definition" : "This is the concept representing the drug source value and may not necessarily be standard. This field is discouraged from use in analysis because it is not required to contain Standard Concepts that are used across the OHDSI community, and should only be used when Standard Concepts do not adequately represent the source detail for the Drug necessary for a given analytic use case. Consider using DRUG_CONCEPT_ID instead to enable standardized analytics that can be consistent across the network.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "Reference",
        "targetProfile" : ["https://aphp.github.io/IG-fhir-dm/StructureDefinition/OMOPConcept"]
      }]
    },
    {
      "id" : "OMOPDrugExposure.route-source-value",
      "path" : "OMOPDrugExposure.route_source_value",
      "short" : "Route Source Value",
      "definition" : "This field houses the verbatim value from the source data representing the drug route.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    },
    {
      "id" : "OMOPDrugExposure.dose-unit-source-value",
      "path" : "OMOPDrugExposure.dose_unit_source_value",
      "short" : "Dose Unit Source Value",
      "definition" : "This field houses the verbatim value from the source data representing the dose unit of the drug given.",
      "min" : 0,
      "max" : "1",
      "type" : [{
        "code" : "string"
      }]
    }]
  }
}

```
